Supreme Showdown

The US Supreme Court is gearing up to hear arguments in the Myriad Genetics gene patenting case on Monday. The Myriad patents cover the isolated BRCA1 and BRCA2 genes, which increase the risk of breast, ovarian, and other cancers, while critics say isolated DNA is a product of nature and, therefore, is not patentable. The implications of a decision in The Association for Molecular Pathology v.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: researchers classify pancreatic cancer into four subtypes using sequencing, and more.

Genotyping analysis of measles in Ontario indicates the strain there didn't originate from Disneyland or Europe.

The UK Medical Research Council says the proposed path of a new train line could affect research at the Francis Crick Institute.

The House of Lords in the UK approves a bill to allow mitochondrial donation.